APPLICATION
BLA761394
TYPE
BLA
ORIGINAL APPROVAL
2025-01-17
LATEST ACTION
2026-05-22
ROUTE
INTRAVENOUS, IV (INFUSION)
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
DATROWAYPrescription
DATOPOTAMAB DERUXTECAN-DLNK 100MG · INJECTABLE · IV (INFUSION)
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.